Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q4 2024 Earnings Call Transcript March 19, 2025
Capricor Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.16, expectations were $-0.31.
Operator: Good afternoon, ladies and gentlemen, and welcome to the Capricor Therapeutics Second (sic) [Fourth] Quarter 2024 Earnings Call. At this time, all participant lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. [Operator Instructions]...
